MDR1 C3435T genetic polymorphism does not influence the response to antiretroviral therapy in drug-naive HIV-positive patients

AIDS

Volumn 17, Issue 11, 2003, Pages 1696-1698

  Nasi, Milena ^a   Borghi, Vanni ^b   Pinti, Marcello ^a   Bellodi, Cristian ^a   Lugli, Enrico ^a   Maffei, Stefania ^a   Troiano, Leonarda ^a   Richeldi, Luca ^b   Mussini, Cristina ^b   Esposito, Roberto ^b   Cossarizza, Andrea ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN P; MULTIDRUG RESISTANCE PROTEIN 1; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; EVALUATION; FEMALE; GENETIC POLYMORPHISM; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; T LYMPHOCYTE;

CD4 LYMPHOCYTE COUNT; GENES, MDR; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HUMANS; POLYMORPHISM, GENETIC; TREATMENT OUTCOME;

EID: 0042127239     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200307250-00016     Document Type: Article

References (7)

1. Bellamy WT. P-glycoproteins and multidrug resistance. Annu Rev Pharmacol Toxicol 1996; 36:161-183.
2. Hoffmeyer S, Burk O, von Richter O, Arnold HP, Brockmoller J, Johne A, et al. Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc Natl Acad Sci U S A 2000; 97:3473-3478.
3. Chaudhary PM, Mechetner EB, Roninson IB. Expression and activity of the multidrug resistance P-glycoprotein in human peripheral blood lymphocytes. Blood 1992; 80:2735-2739.
4. Brinkmann U. Functional polymorphisms of the human multidrug resistance (MDR1) gene: correlation with P glycoprotein expression and activity in vivo. Novartis Found Symp 2002; 243:207-210.
5. Fellay J, Marzolini C, Meaden ER, Back DJ, Buclin T, Chave JP, et al. Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study. Lancet 2002; 359:30-36.
6. Pinti M, Troiano L, Nasi M, Moretti L, Monterastelli E, Mazzacani A, et al. Genetic polymorphisms of Fas (CD95) and FasL (CD178) in human longevity: studies on centenarians. Cell Death Differ 2002; 9:431-438.
7. Mussini C, Pinti M, Borghi V, Nasi M, Amorico G, Monterastelli E, et al. Immunological features of "CD4 exploders", a group of HAART-treated, HIV+ patients with an optimal reconstitution of the immune system. AIDS 2002; 16:1609-1616.